EGFR activation elicited adaptive resistance to lorlatinib in ALK-rearranged non-small cell lung cancer cells

被引：0
|
作者：
Katayama, Yuki [1 ]
Yamada, Tadaaki [1 ]
Tanimura, Keiko [1 ]
Morimoto, Kenji [1 ]
Yoneda, Kazue [2 ]
Horinaka, Mano [3 ]
Sakai, Toshiyuki [3 ]
Ozasa, Hiroaki [4 ]
Takayama, Koichi [1 ]
机构：
[1] Kyoto Prefectural Univ Med, Dept Pulm Med, Grad Sch Med Sci, Kyoto, Japan
[2] Hyogo Coll Med, Dept Omics Med, Nishinomiya, Hyogo, Japan
[3] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Drug Discovery Med, Kyoto, Japan
[4] Kyoto Univ, Grad Sch Med, Dept Resp Med, Kyoto, Japan
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MO38-3
引用
收藏
页码：S1421 / S1421
页数：1
相关论文
共 50 条
  • [1] Adaptive resistance to lorlatinib by EGFR activation in ALK-rearranged non-small cell lung cancer cells
    Katayama, Yuki
    Tanimura, Keiko
    Morimoto, Kenji
    Horinaka, Mano
    Sakai, Toshiyuki
    Ozasa, Hiroaki
    Yamada, Tadaaki
    CANCER SCIENCE, 2023, 114 : 1474 - 1474
  • [2] Adaptive resistance to lorlatinib by EGFR activation in ALK-rearranged non-small cell lung cancer cells
    Katayama, Yuki
    Tanimura, Keiko
    Morimoto, Kenji
    Horinaka, Mano
    Sakai, Toshiyuki
    Ozasa, Hiroaki
    Yamada, Tadaaki
    CANCER SCIENCE, 2023, 114 : 830 - 830
  • [3] Adaptive resistance to lorlatinib via EGFR signaling in ALK-rearranged lung cancer
    Yuki Katayama
    Tadaaki Yamada
    Keiko Tanimura
    Shinsaku Tokuda
    Kenji Morimoto
    Soichi Hirai
    Yohei Matsui
    Ryota Nakamura
    Masaki Ishida
    Hayato Kawachi
    Kazue Yoneda
    Kazutaka Hosoya
    Takahiro Tsuji
    Hiroaki Ozasa
    Akihiro Yoshimura
    Masahiro Iwasaku
    Young Hak Kim
    Mano Horinaka
    Toshiyuki Sakai
    Takahiro Utsumi
    Shinsuke Shiotsu
    Takayuki Takeda
    Ryohei Katayama
    Koichi Takayama
    npj Precision Oncology, 7
  • [4] Adaptive resistance to lorlatinib via EGFR signaling in ALK-rearranged lung cancer
    Katayama, Yuki
    Yamada, Tadaaki
    Tanimura, Keiko
    Tokuda, Shinsaku
    Morimoto, Kenji
    Hirai, Soichi
    Matsui, Yohei
    Nakamura, Ryota
    Ishida, Masaki
    Kawachi, Hayato
    Yoneda, Kazue
    Hosoya, Kazutaka
    Tsuji, Takahiro
    Ozasa, Hiroaki
    Yoshimura, Akihiro
    Iwasaku, Masahiro
    Kim, Young Hak
    Horinaka, Mano
    Sakai, Toshiyuki
    Utsumi, Takahiro
    Shiotsu, Shinsuke
    Takeda, Takayuki
    Katayama, Ryohei
    Takayama, Koichi
    NPJ PRECISION ONCOLOGY, 2023, 7 (01)
  • [5] EGFR activation via c-Jun axis promotes adaptive resistance to third generation ALK-TKI lorlatinib in ALK-rearranged non-small cell lung cancer cells
    Katayama, Yuki
    Yamada, Tadaaki
    Morimoto, Kenji
    Ozasa, Hiroaki
    Tokuda, Shinsaku
    Takayama, Koichi
    CANCER RESEARCH, 2023, 83 (07)
  • [6] Overcoming crizotinib resistance in ALK-rearranged non-small cell lung cancer
    Qi, Xiaolong
    Ma, Wang
    Li, Sen
    Zhou, Caicun
    LUNG CANCER, 2014, 85 (02) : 335 - 336
  • [7] Lorlatinib in ALK-Rearranged Lung Cancer
    Kuang, Shelley
    Leighl, Natasha B.
    CANCER CELL, 2021, 39 (01) : 25 - 27
  • [8] The Resistance Mechanisms and Treatment Strategies for ALK-Rearranged Non-Small Cell Lung Cancer
    Pan, Yue
    Deng, Chao
    Qiu, Zhenhua
    Cao, Chenghui
    Wu, Fang
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [9] TARGETING ALK-REARRANGED NON-SMALL CELL LUNG CARCINOMA
    Iafrate, J.
    Kwak, E.
    Bang, Y.
    Solomon, B.
    Shaw, A.
    Camidge, D. R.
    Ou, S. H.
    Maki, R.
    Salgia, R.
    Clark, J.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) : S20 - S20
  • [10] Cystic brain metastases in ALK-rearranged non-small cell lung cancer
    Marta, Guilherme Nader
    da Cunha Colombo Bonadio, Renata Rodrigues
    Martins, Renata Eiras
    Zuppani, Henrique Bortot
    de Castro Junior, Gilberto
    ECANCERMEDICALSCIENCE, 2018, 12
12345